Download PDF
Thromb Haemost 1997; 78(02): 834-839
DOI: 10.1055/s-0038-1657637
Rapid Communication
Schattauer GmbH Stuttgart

Factor XI Activation by Meizothrombin: Stimulation by Phospholipid Vesicles Containing both Phosphatidylserine and Phosphatidylethanolamine

Peter A Kr von dem Borne
1   The Dept. of Haematology, University Hospital Utrecht, The Netherlands
,
Laurent O Mosnier
1   The Dept. of Haematology, University Hospital Utrecht, The Netherlands
,
Guido Tans
2   The Dept. of Biochemistry, Cardiovascular Research Institute, University of Limburg, Maastricht, The Netherlands
,
Joost C M Meijers
1   The Dept. of Haematology, University Hospital Utrecht, The Netherlands
,
Bonno N Bouma
1   The Dept. of Haematology, University Hospital Utrecht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 12 1996

Accepted after resubmission 09 April 1997

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The activation of factor XI by meizothrombin was investigated using recombinant meizothrombin (R155A meizothrombin) that is resistant to autocatalytic removal of fragment 1. Meizothrombin was capable of activating factor XI at an activation rate similar to that of thrombin. Dextran sulphate and heparin, known cofactors of thrombin-mediated factor XI activation, did not stimulate the activation of factor XI by meizothrombin. However, the activation of factor XI by meizothrombin was markedly enhanced by vesicles containing phosphatidylcholine (PC), phosphatidylserine (PS) and phosphatidylethanolamine (PE), whereas PC/PS or PC/PE vesicles only had a minor effect on the activation. Thrombin-mediated factor XI activation was not influenced by phospholipids.

The effect of PC/PS/PE and PC/PS vesicles was studied in a factor XI dependent clot lysis assay. In this assay, factor XI inhibits clot lysis by a feedback loop in the intrinsic pathway via thrombin-mediated factor XI activation. Removal of endogenous phospholipids in plasma by centrifugation resulted in an increased clot lysis, which could be restored to the pre-centrifugation level by the addition of PC/PS/PE vesicles, but not by PC/PS vesicles. When clot lysis was initiated by factor IXa in the presence of a factor XIa blocking antibody, there was no difference in inhibitory effect of PC/PS/PE or PC/PS vesicles. These data suggested that the differences in clot lysis inhibition observed between PC/PS/PE and PC/PS vesicles were caused by factor XI activation by meizothrombin. Meizothrombin-mediated factor XI activation may therefore play an important role in the antifibrinolytic feedback loop in the intrinsic pathway.

 

  • References

  • 1 Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991; 266: 7353-7358
    PubMedGoogle Scholar
  • 2 Gailani D, Broze GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-912
    CrossrefPubMedGoogle Scholar
  • 3 Gailani D, Broze GJ. Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul Fibrinolysis 1993; 4: 15-20
    CrossrefPubMedGoogle Scholar
  • 4 Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. Thromb Haemost 1991; 65: 144 (Abstract).
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Gailani D, Broze GJ. Factor XH-independent activation of factor XI in plasma: effect of sulfatides on tissue factor-induced coagulation. Blood 1993; 82: 813-819
    PubMedGoogle Scholar
  • 6 von demBome PAK, Koppelman SJ, Bouma BN, Meijers JCM. Surface independent activation of factor XI by thrombin in the presence of high molecular weight kininogen. Thromb Haemost 1994; 72: 397-402
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 von demBome PAK, Meijers JCM, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995; 86: 3035-3042
    CrossrefPubMedGoogle Scholar
  • 8 Mann KG, Nesheim WR, Church WR, Haley P, Krishaswamy S. Surfacedependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16
    PubMedGoogle Scholar
  • 9 Mann KG, Krishnaswamy S, Lawson JH. Surface-dependent hemostasis. Semin Hematol 1992; 29: 213-226
    PubMedGoogle Scholar
  • 10 Rosing J, Tans G. Meizothrombin, a major product of factor Xa-catalyzed prothrombin activation. Thromb Haemost 1988; 60: 355-360
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Doyle M, Haley PE. Meizothrombin: active intermediate formed during prothrombinase-catalyzed activation of prothrombin. Methods Enzymol 1993; 222: 299-312
    PubMedGoogle Scholar
  • 12 Rosing J, Zwaal RFA, Tans G. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation. J Biol Chem 1986; 261: 4224-4228
    PubMedGoogle Scholar
  • 13 Doyle MF, Mann KG. Multiple active forms of thrombin. IV.Relative activities of meizothrombins. J Biol Chem 1990; 265: 10693-10701
    PubMedGoogle Scholar
  • 14 Tans G, Nicolaes GAF, Christella M, Thomassen LGD, Hemker HC, van ZonneveldAJ, Pannekoek H, Rosing J. Activation of human factor V by meizothrombin. J Biol Chem 1994; 269: 15969-15972
    PubMedGoogle Scholar
  • 15 Schoen P, Lindhout T. The in situ inhibition of prothrombinase formed human α-thrombin and meizothrombin (desFl) by antithrombin III and heparin. J Biol Chem 1987; 262: 11268-11274
    PubMedGoogle Scholar
  • 16 Krishnaswamy S, Mann KG, Nesheim ME. The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction. J Biol Chem 1986; 261: 8977-8984
    CrossrefPubMedGoogle Scholar
  • 17 Tijburg PNM, van HeerdeWL, Leenhouts HM, Hessing M, Bouma BN, de GrootPhG. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation on endothelial cells. The influence of thrombin on the reaction mechanism. J Biol Chem 1991; 266: 4017-4022
    PubMedGoogle Scholar
  • 18 Tans G, Janssen-Claessen T, Hemker HC, Zwaal RFA, Rosing J. Meizothrombin formation during factor Xa-catalyzed prothrombin activa-tion. Formation in a purified system and in plasma. J Biol Chem 1991; 266: 21864-21873
    PubMedGoogle Scholar
  • 19 Bovill EG, Tracy RP, Hayes TE, Jenny RJ, Bhushan FH, Mann KG. Evidence that meizothrombin is an intermediate product in clotting whole blood. Arterioscler Thromb Vase Biol 1995; 15: 754-758
    CrossrefPubMedGoogle Scholar
  • 20 Miletich JP, Jackson CM, Majerus PW. Properties of the factor Xa binding site on platelets. J Biol Chem 1978; 253: 6908-6916
    PubMedGoogle Scholar
  • 21 van derGraaf F, Greengard JS, Bouma BN, Kerbiriou DM, Griffin JH. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI. J Biol Chem 1983; 258: 9669-9675
    PubMedGoogle Scholar
  • 22 Ahmad SS, Rawala-Sheikh R, Walsh PN. Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem 1989; 264: 3244-3251
    CrossrefPubMedGoogle Scholar
  • 23 Brunner J, Skrabal P, Hauser H. Single bilayer vesicles prepared without sonication. Physico-chemical properties. Biochim Biophys Acta 1976; 455: 322-331
    CrossrefPubMedGoogle Scholar
  • 24 Rouser G, Fleisher S, Yamamoto A. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipid by phosphorus analysis of spots. Lipids 1970; 5: 494-496
    CrossrefPubMedGoogle Scholar
  • 25 Meijers JCM. Regulation of the blood coagulation mechanism by plasma proteinase inhibitors. PhD Thesis, State University of Utrecht, The Netherlands. 1988 pp. 93-108
    PubMedGoogle Scholar
  • 26 Uchida T, Filbum CR. Affinity chromatography of protein kinase C-phorbol ester receptor on polyacrylamide-immobilized phosphatidylserine. J Biol Chem 1984; 259: 12311-12314
    PubMedGoogle Scholar
  • 27 Rhee MJ, Morris S, Kosow DP. Role of meizothrombin and meizothrom-bin(desFl) in the conversion of prothrombin to thrombin by the Echis carinatus venom coagulant. Biochemistry 1988; 21: 3437-3443
    PubMedGoogle Scholar
  • 28 Pei G, Laue TM, Aulabaugh A, Fowlkes DM, Lentz BR. Structural comparisons of meizothrombin and its precursor prothrombin in the presence or absence of membranes. Biochemistry 1992; 31: 6990-6996
    CrossrefPubMedGoogle Scholar
  • 29 Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66
    CrossrefPubMedGoogle Scholar
  • 30 Bevers EM, Comfurius P, Zwaal RFA. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev 1991; 5: 146-154
    CrossrefPubMedGoogle Scholar
  • 31 Neuenschwander PF, Bianco-Fisher E, Rezaie AR, Morrissey JH. Phosphatidylethanolamine augments factor Vlla-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry 1995; 34: 13988-13993
    CrossrefPubMedGoogle Scholar
  • 32 Smirnov MD, Esmon CT. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 1994; 269: 816-819
    PubMedGoogle Scholar